LON:HZD - Horizon Discovery Group Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
GBX 168.25 +2.25 (+1.36 %)
(As of 07/16/2018 02:31 AM ET)
Previous CloseGBX 166
Today's RangeGBX 166.50 - GBX 173
52-Week RangeGBX 160 - GBX 294
Volume1.62 million shs
Average Volume258,981 shs
Market Capitalization£256.44 million
P/E RatioN/A
Dividend YieldN/A
Horizon Discovery Group logoHorizon Discovery Group plc, an integrated life science company, designs, manufactures, and applies gene editing and gene modulation to build cell models that harbour the genetics of human disease in the Americas, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company operates through Products, Services, and Leveraged Research and Development (R&D) segments. Its core capabilities are built around its proprietary transnational genomics platform, a suite of gene editing tools to alter gene sequence in human or mammalian cell-lines. The company offers various research products, including cell lines that help researchers to understand how complex genetic diseases manifest themselves in patients; research reagents, which enable researchers to silence genes with the use of RNAi and express or overexpress genes through tools, such as cDNA, as well as permanently edit genes with CRISPR reagents; and in vivo research models for specialized R&D applications, and to support preclinical drug development programs. It also provides reference standards that are used as a source of genetically defined, quantitative, sustainable, and independent third-party reference material, as well as for validation and routine performance monitoring of assays; and bio-production cell lines licenses. In addition, the company offers cell and in vivo custom model generation, assay, and genetic and molecular screening services, as well as screening publications. Further, it is involved in the leverages R&D activity. The company serves customers in academic research, drug discovery and manufacturing, and clinical diagnostics markets. It sells its products through direct sales channel and e-commerce platform. Horizon Discovery Group plc was founded in 2007 and is headquartered in Cambridge, the United Kingdom.

Receive HZD News and Ratings via Email

Sign-up to receive the latest news and ratings for HZD and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange LON
Industry Biotechnology


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-67.89%
Return on Equity-22.22%
Return on Assets-19.35%


Outstanding Shares148,930,000
Market Cap£256.44

The Truth About Cryptocurrencies

Horizon Discovery Group (LON:HZD) Frequently Asked Questions

What is Horizon Discovery Group's stock symbol?

Horizon Discovery Group trades on the London Stock Exchange (LON) under the ticker symbol "HZD."

What price target have analysts set for HZD?

4 equities research analysts have issued twelve-month price objectives for Horizon Discovery Group's shares. Their forecasts range from GBX 181 to GBX 245. On average, they expect Horizon Discovery Group's stock price to reach GBX 225.25 in the next year. This suggests a possible upside of 33.9% from the stock's current price. View Analyst Ratings for Horizon Discovery Group.

What is the consensus analysts' recommendation for Horizon Discovery Group?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Horizon Discovery Group in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Who are some of Horizon Discovery Group's key competitors?

Who are Horizon Discovery Group's key executives?

Horizon Discovery Group's management team includes the folowing people:
  • Dr. Ian David Gilham, Exec. Chairman (Age 59)
  • Mr. Richard John Vellacott, CFO & Director (Age 43)
  • Mr. Terence William Pizzie, CEO & Director (Age 57)
  • Dr. Chris Torrance, Co-Founder & Member of Scientific Advisory Board
  • Prof. Alberto Bardelli Ph.D., Co-Founder & Chairman of Scientific Advisory Board

Has Horizon Discovery Group been receiving favorable news coverage?

News stories about HZD stock have trended somewhat positive recently, Accern Sentiment Analysis reports. The research group rates the sentiment of media coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Horizon Discovery Group earned a news sentiment score of 0.05 on Accern's scale. They also gave news articles about the company an impact score of 44.47 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company's share price in the immediate future.

How do I buy shares of Horizon Discovery Group?

Shares of HZD and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Horizon Discovery Group's stock price today?

One share of HZD stock can currently be purchased for approximately GBX 168.25.

How big of a company is Horizon Discovery Group?

Horizon Discovery Group has a market capitalization of £256.44 million.

How can I contact Horizon Discovery Group?

Horizon Discovery Group's mailing address is 8100 Cambridge Research Park Beach Drive, CAMBRIDGE, CB25 9TL, United Kingdom. The company can be reached via phone at +44-1223-976000.

MarketBeat Community Rating for Horizon Discovery Group (LON HZD)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  354 (Vote Outperform)
Underperform Votes:  213 (Vote Underperform)
Total Votes:  567
MarketBeat's community ratings are surveys of what our community members think about Horizon Discovery Group and other stocks. Vote "Outperform" if you believe HZD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HZD will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/16/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.